• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Eye Science >Triamcinolone-assisted Pars Plana Vitrectomy for Retinal Disease
【24h】

Triamcinolone-assisted Pars Plana Vitrectomy for Retinal Disease

机译：曲安西龙辅助的Pars平板玻璃体切除术治疗视网膜疾病

获取原文
获取原文并翻译 | 示例
       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Purpose: To determine whether triamcinolone acetonide(TA) staining facilitates posterior hyaloid removal in patients undergoing pars plana vitrectomy (PPV) for retinal disease. Methods: A triamcinolone acetonide(TA)-assisted vitrectomy was performed on patients with the following disease: proliferative diabetic retionpathy(5eyes), central retinal vein occlusion(5eyes), macuar hole (5eyes), and epiretinal membrane(2eyes). Eyes without apparent preoperative posterior vitreous detachment were enrolled in this study. After a core PPV, TA aqueous suspension (40 mg/ml) was injected into the mid vitreous cavity to visualize the posterior hyaloid, thus allowing a complete posterior hyaloid separation and removal. The visual acuity, intraocular pressure(IOP), tamponade, corneal pathology, after-cataract, vitreous hemorrhage, and necessity for reoperation were thereafter examined for at least 3 months after surgery. Results: In all patients, the vitreous body was clearly seen by means of triamcinolone during surgery, and complete removal of posterior hyaloid was facilitated and confirmed. Retina was attached in 14 of 15 eyes, and vision acuity was improved in 9 of 15 eyes. Two eyes showed transient postoperative IOP elevation, 2 eyes had after cataract formation and leye had cataract progression. Vitreous hemorrhage occurred in 1 eye. No eye had corneal pathology. Conclusion: Triamcinolone improved the visibility of the hyaloid and the safety of surgical procedures during PPV. No obvious adverse effect due to toxicity of TA accrued in TA-assisted PPV.
机译：目的：确定曲安奈德（TA）染色是否有助于进行视网膜玻璃体切除术（PPV）的患者的后玻璃体切除。方法：对患有以下疾病的患者进行曲安奈德（TA）辅助玻璃体切割术：增生性糖尿病反应病（5眼），视网膜中央静脉阻塞（5眼），黄斑孔（5眼）和视网膜前膜（2眼）。没有明显的术前玻璃体后脱离的眼睛参加了这项研究。在核心PPV之后，将TA水性混悬液（40 mg / ml）注入玻璃体中腔，以可视化后玻璃体，从而完全分离并去除后玻璃体。术后至少3个月检查视力，眼压（IOP），填塞物，角膜病理，白内障，玻璃体出血和再次手术的必要性。结果：在所有患者中，术中均使用曲安奈德清晰可见玻璃体，并促进并确认了透明后玻璃体的完全清除。视网膜附着在15眼中的14眼中，视力提高了15眼中的9眼。术后出现暂时性IOP升高的有两只眼，白内障形成后有2眼，而leye有白内障的进展。 1只眼发生玻璃体出血。没有眼睛有角膜病理。结论：曲安奈德改善了PPV期间透明质酸的可见性和手术程序的安全性。由于在TA辅助的PPV中产生的TA毒性，没有明显的不良影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号